A trackable trinuclear platinum complex for breast cancer treatment

Cancer remains a leading cause of death, with triple-negative breast cancer (TNBC) being particularly significant due to limited treatment options. As such, there is interest in anticancer polynuclear platinum(II) complexes, attributed to their unique DNA-binding modes and potential against therapy-resistant cancer phenotypes. However, a persistent challenge with polynuclear compounds is their lack of cellular trackability, hindering their effectiveness and monitoring in clinical settings. Here, we report the preparation of a new azide-appended trinuclear platinum complex, N3-TriplatinNC, and characterize its DNA-targeting, cytotoxicity, and topoisomerase relaxation properties from the nanoscale to the macroscale. Using single-molecule biophysics and in-liquid atomic force microscopy, N3-TriplatinNC was identified as a powerful DNA recognition agent with remarkable potential towards the TNBC cell line, MDA-MB-231. Installation of the azide handle on the polynuclear complex was achieved using a first-in-class approach to produce a complex that retained analogous biological activity to the parent TriplatinNC. Importantly, the azide handle facilitates in situ click chemistry for tracking cellular localization, with subsequent xenograft studies demonstrating in vivo antitumoural potential.

Authors

Institutions

Publication Details

Journal
Nucleic Acids Research
Published
2025-06-24
DOI
https://doi.org/10.1093/nar/gkaf628
Citations
2
Primary Topic
Advanced biosensing and bioanalysis techniques
Type
article
Field-Weighted Citation Impact
1.61

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A trackable trinuclear platinum complex for breast cancer treatment

Andrew Kellett, Stefano Scoditti, Katarzyna Mnich, Sylvia Whittle et al.
2 citations
Nucleic Acids Research
Advanced biosensing and bioanalysis techniques
1.61
article

A trackable trinuclear platinum complex for breast cancer treatment

Andrew Kellett, Stefano Scoditti, Katarzyna Mnich, Sylvia Whittle, Creina Slator, Afshin Samali, Sriram KK, Bin Hu, Bethany Searle, Conor Newsome, Erica J. Peterson, Thomas E. Catley, Raphael Enoque Ferraz de Paiva, Jennifer E. Koblinski, Nicholas P. Farrell, Alice L. B. Pyne, Fredrik Westerlund, Sinéad O’Carroll, Vickie McKee
article en
2 citations

Abstract

Cancer remains a leading cause of death, with triple-negative breast cancer (TNBC) being particularly significant due to limited treatment options. As such, there is interest in anticancer polynuclear platinum(II) complexes, attributed to their unique DNA-binding modes and potential against therapy-resistant cancer phenotypes. However, a persistent challenge with polynuclear compounds is their lack of cellular trackability, hindering their effectiveness and monitoring in clinical settings. Here, we report the preparation of a new azide-appended trinuclear platinum complex, N3-TriplatinNC, and characterize its DNA-targeting, cytotoxicity, and topoisomerase relaxation properties from the nanoscale to the macroscale. Using single-molecule biophysics and in-liquid atomic force microscopy, N3-TriplatinNC was identified as a powerful DNA recognition agent with remarkable potential towards the TNBC cell line, MDA-MB-231. Installation of the azide handle on the polynuclear complex was achieved using a first-in-class approach to produce a complex that retained analogous biological activity to the parent TriplatinNC. Importantly, the azide handle facilitates in situ click chemistry for tracking cellular localization, with subsequent xenograft studies demonstrating in vivo antitumoural potential.

Nucleic Acids ResearchVol. 53(13)
University of the Basque Country (ES), Virginia Commonwealth University (US), Ollscoil na Gaillimhe – University of Galway (IE), COPE Galway (IE), Dublin City University (IE), University of Calabria (IT), Donostia International Physics Center (ES), Chalmers University of Technology (SE), University of Sheffield (GB)
Swedish Cancer Foundation, Ministerio de Ciencia, Innovación y Universidades, Science Foundation Ireland, Irish Research Council, Vetenskapsrådet, Novo Nordisk Fonden, Engineering and Physical Sciences Research Council, European Social Fund, H2020 European Research Council
Good health and well-being
Openalex Percentile: Top 16%
Advanced biosensing and bioanalysis techniques
1.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.